These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 18510489)

  • 21. Hypertension alone or related to the metabolic syndrome in postmenopausal women.
    Nuzzo A; Rossi R; Modena MG
    Expert Rev Cardiovasc Ther; 2010 Nov; 8(11):1541-8. PubMed ID: 21090929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ambulatory blood pressure monitoring versus self-measurement of blood pressure at home: correlation with target organ damage.
    Gaborieau V; Delarche N; Gosse P
    J Hypertens; 2008 Oct; 26(10):1919-27. PubMed ID: 18806615
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is retinal arteriolar-venular ratio associated with cardiac and extracardiac organ damage in essential hypertension?
    Masaidi M; Cuspidi C; Giudici V; Negri F; Sala C; Zanchetti A; Grassi G; Mancia G
    J Hypertens; 2009 Jun; 27(6):1277-83. PubMed ID: 19357533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Asthma-like symptoms are increased in the metabolic syndrome.
    Lee EJ; In KH; Ha ES; Lee KJ; Hur GY; Kang EH; Jung KH; Lee SY; Kim JH; Lee SY; Shin C; Shim JJ; Kang KH; Yoo SH
    J Asthma; 2009 May; 46(4):339-42. PubMed ID: 19484665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kidney function and clinical correlates in newly diagnosed hypertensives attending a university teaching hospital in southwest Nigeria.
    Ayodele OE; Egbewale BE; Alebiosu CO
    Afr J Med Med Sci; 2007 Jun; 36(2):95-101. PubMed ID: 19205569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia.
    Gündogan K; Bayram F; Capak M; Tanriverdi F; Karaman A; Ozturk A; Altunbas H; Gökce C; Kalkan A; Yazici C
    Metab Syndr Relat Disord; 2009 Oct; 7(5):427-34. PubMed ID: 19754305
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The metabolic syndrome in hypertension: European society of hypertension position statement.
    Redon J; Cifkova R; Laurent S; Nilsson P; Narkiewicz K; Erdine S; Mancia G;
    J Hypertens; 2008 Oct; 26(10):1891-900. PubMed ID: 18806611
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic syndrome: at the crossroads of cardiorenal risk.
    Natali A; Pucci G; Boldrini B; Schillaci G
    J Nephrol; 2009; 22(1):29-38. PubMed ID: 19229816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between severity of lower urinary tract symptoms, erectile dysfunction and metabolic syndrome.
    Demir O; Akgul K; Akar Z; Cakmak O; Ozdemir I; Bolukbasi A; Can E; Gumus BH
    Aging Male; 2009 Mar; 12(1):29-34. PubMed ID: 19326294
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between pregnancy-related hypertension and severity of hypertension.
    Moreira LB; Gus M; Nunes G; Gonçalves CB; Martins J; Wiehe M; Fuchs FD
    J Hum Hypertens; 2009 Jun; 23(6):415-9. PubMed ID: 19020534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Target organ damage and cardiovascular risk factors among subjects with previously undiagnosed hypertension.
    Korhonen PE; Kautiainen H; Järvenpää S; Kantola I
    Eur J Prev Cardiol; 2014 Aug; 21(8):980-8. PubMed ID: 23335655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence and predictors of metabolic syndrome among patients attending an outpatient clozapine clinic in Australia.
    Brunero S; Lamont S; Fairbrother G
    Arch Psychiatr Nurs; 2009 Jun; 23(3):261-8. PubMed ID: 19446781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Which markers of subclinical organ damage to measure in individuals with high normal blood pressure?
    Sehestedt T; Jeppesen J; Hansen TW; Rasmussen S; Wachtell K; Ibsen H; Torp-Pedersen C; Olsen MH
    J Hypertens; 2009 Jun; 27(6):1165-71. PubMed ID: 19387364
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of silent cerebrovascular disease refines risk stratification of hypertensive patients.
    Henskens LH; van Oostenbrugge RJ; Kroon AA; Hofman PA; Lodder J; de Leeuw PW
    J Hypertens; 2009 Apr; 27(4):846-53. PubMed ID: 19300113
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The metabolic syndrome: definitions, prevalence and management.
    Levesque J; Lamarche B
    J Nutrigenet Nutrigenomics; 2008; 1(3):100-8. PubMed ID: 19776619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum uric acid is independently associated with metabolic syndrome in subjects with and without a low estimated glomerular filtration rate.
    See LC; Kuo CF; Chuang FH; Li HY; Chen YM; Chen HW; Yu KH
    J Rheumatol; 2009 Aug; 36(8):1691-8. PubMed ID: 19531754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between peripheral arterial disease and metabolic syndrome.
    Maksimovic M; Vlajinac H; Radak D; Marinkovic J; Jorga J
    Angiology; 2009; 60(5):546-53. PubMed ID: 19147526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The metabolic syndrome in Japan.
    Fujita T
    Nat Clin Pract Cardiovasc Med; 2008 Jul; 5 Suppl 1():S15-8. PubMed ID: 18580861
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical study of the risk factors of insulin resistance and metabolic syndrome after kidney transplantation.
    Sui W; Zou H; Zou G; Yan Q; Chen H; Che W; Xie S
    Transpl Immunol; 2008 Nov; 20(1-2):95-8. PubMed ID: 18703143
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Metabolic syndrome as cardiovascular risk factor].
    Dłuzniewski M; Mamcarz A
    Kardiol Pol; 2005 Jun; 62 Suppl 2():II28-9. PubMed ID: 19813332
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.